Glutaric aciduria type 1
Glutaric aciduria type 1 is a rare genetic disorder that affects the body's ability to break down certain proteins. It is characterized by a deficiency of the enzyme glutaryl-CoA dehydrogenase, which is involved in the breakdown of the amino acids lysine, hydroxylysine, and tryptophan. This deficiency leads to an accumulation of glutaric acid, 3-hydroxyglutaric acid, and glutaconic acid in the body, which can cause a variety of symptoms.
Symptoms[edit | edit source]
The symptoms of glutaric aciduria type 1 can vary widely, but they typically include macrocephaly (an unusually large head), developmental delay, and movement disorders. Other symptoms can include seizures, spasticity (stiff or rigid muscles), and dystonia (involuntary muscle contractions). In severe cases, the condition can lead to coma or death.
Causes[edit | edit source]
Glutaric aciduria type 1 is caused by mutations in the GCDH gene, which provides instructions for making the enzyme glutaryl-CoA dehydrogenase. This enzyme is involved in the breakdown of certain amino acids. When the GCDH gene is mutated, the enzyme's activity is reduced or eliminated, leading to an accumulation of harmful substances in the body.
Diagnosis[edit | edit source]
The diagnosis of glutaric aciduria type 1 is typically made through a combination of clinical examination, biochemical testing, and genetic testing. Biochemical testing involves measuring the levels of certain substances in the body, while genetic testing involves looking for mutations in the GCDH gene.
Treatment[edit | edit source]
There is currently no cure for glutaric aciduria type 1, but the condition can be managed with a combination of dietary restrictions, medications, and physical therapy. Dietary restrictions typically involve limiting the intake of certain amino acids, while medications can help manage symptoms such as seizures and movement disorders. Physical therapy can help improve muscle tone and coordination.
See also[edit | edit source]
Glutaric aciduria type 1 Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD